î Stoke Therapeutics Incã®çŸåšã®è²¡åã¹ã³ã¢ã¯6.32ã§ãã ãã®è²¡åç¶æ³ã¯å
調ã§ãã ãŸããäºæ¥å¹çã¯äœãã§ãã ææ°ååæã®å£²äžé«ã¯11.26Mã§ãåå¹Žåææ¯å¢å ã®5.86%ã§ãããäžæ¹ãçŽå©çã¯åå¹Žåææ¯å¢å ã®92.05%ãšãªããŸããã
î Stoke Therapeutics Incã®çŸåšã®ããªã¥ãšãŒã·ã§ã³ã¹ã³ã¢ã¯7.67ã§ãã çŸåšã®PERã¯-9.33ã§ãçŽè¿é«å€54.03ã-679.19%äžåããçŽè¿å®å€-320.57ã-3336.40%äžåã£ãŠããŸãã
î Stoke Therapeutics Incã®çŸåšã®åçäºæž¬ã¹ã³ã¢ã¯8.86ã§ãã ç®æšæ ªäŸ¡ã®å¹³åã¯46.92ã§ãæé«ã¯60.00ãæäœã¯35.00ã§ãã
î Stoke Therapeutics Incã®çŸåšã®äŸ¡æ Œã¢ã¡ã³ã¿ã ã¹ã³ã¢ã¯3.81ã§ãã çŸåšãæ ªäŸ¡ã¯æµæç·28.70ãšæ¯æç·24.39ã®éã§æšç§»ããŠãããã¬ã³ãžçžå Žã§ã®ã¹ã€ã³ã°ãã¬ãŒãã«é©ããŠããŸãã
î Stoke Therapeutics Incã®çŸåšã®æ©é¢æè³å®¶ææ ªã¹ã³ã¢ã¯10.00ã§ãã ææ°ã®æ©é¢æè³å®¶ä¿ææ¯çã¯118.29%ã§ãåååææ¯æžå°3.39%ã§ãã
î Stoke Therapeutics Incã®çŸåšã®ãªã¹ã¯è©äŸ¡ã¹ã³ã¢ã¯6.37ã§ãã å瀟ã®ããŒã¿å€ã¯1.19ã§ãã ããã¯ãäžæçžå Žã§ã¯æ ªäŸ¡ãåžå Žå
šäœïŒææ°ïŒãäžåãåŸåãããäžæ¹ã§ãäžèœçžå Žã§ã¯ãã倧ããªäžèœãçµéšããããšã瀺ããŠããŸãã